HARVEY CAPITAL MANAGEMENT INC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 124 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
HARVEY CAPITAL MANAGEMENT INC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$735,000
-39.2%
54,7500.0%0.29%
-28.4%
Q2 2015$1,209,000
+8.1%
54,750
-30.1%
0.41%
-0.5%
Q1 2015$1,118,000
+47.1%
78,350
-0.6%
0.41%
+41.2%
Q4 2014$760,000
-76.0%
78,850
-77.4%
0.29%
-76.6%
Q3 2014$3,171,000
-18.7%
348,550
-11.7%
1.24%
-10.8%
Q2 2014$3,898,000
-21.7%
394,550
+0.6%
1.40%
-29.8%
Q1 2014$4,980,000
+55.3%
392,050
+83.2%
1.99%
+49.9%
Q4 2013$3,207,000
+332.8%
214,000
+218.5%
1.32%
+252.4%
Q3 2013$741,00067,2000.38%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders